Skip to main content
NCBI home page
Cell Cycle logoLink to Cell Cycle
. 2012 Oct 1;11(19):3703. doi: 10.4161/cc.22288

Erratum to Ponassi R, et al. Cell Cycle Volume 7, Issue 20; pp. 3211-24

Raffaella Ponassi 1,2, Barbara Biasotti 1,2, Valeria Tomati 1,2, Silvia Bruno 3, Alessandro Poggi 4, Davide Malacarne 2, Guido Cimoli 5, Annalisa Salis 6, Sarah Pozzi 7, Maurizio Miglino 8, Gianluca Damonte 6, Pietro Cozzini 9, Francesca Spyrakis 9,*, Barbara Campanini 9, Luca Bagnasco 1,2, Nicoletta Castagnino 1,2, Lorenzo Tortolina 1,2, Anna Mumot 1,2, Francesco Frassoni 7, Antonio Daga 10, Michele Cilli 11, Federica Piccardi 11, Ilaria Monfardini 12, Miriam Perugini 12, Gabriele Zoppoli 12, Cristina D’Arrigo 13, Raffaele Pesenti 14, Silvio Parodi 1,2
PMCID: PMC3478321

It has come to attention of the Editorial Staff that in the report, “A novel Bim-BH3-derived Bcl-XL inhibitor: Biochemical characterization, in vitro, in vivo and ex-vivo anti-leukemic activity” in Cell Cycle Volume 7, Issue 20, the name of one author was misspelled. Rather than Francesca Spyraki, the author list should have read Francesca Spyrakis.

Ponassi R, Biasotti B, Tomati V, Bruno S, Poggi A, Malacarne D, et al. A novel Bim-BH3-derived Bcl-XL inhibitor: biochemical characterization, in vitro, in vivo and ex-vivo anti-leukemic activity. Cell Cycle. 2008;7:3211–24. doi: 10.4161/cc.7.20.6830.

Footnotes

Articles from Cell Cycle are provided here courtesy of Taylor & Francis

RESOURCES